Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract

被引:155
作者
Wen, Zhiming [1 ]
Dumas, Todd E. [1 ,3 ]
Schrieber, Sarah J. [1 ]
Hawke, Roy L. [1 ]
Fried, Michael W. [2 ]
Smith, Philip C. [1 ]
机构
[1] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA
[3] Quintiles Inc, PK PD Modeling & Simulat, Kansas City, MO USA
关键词
D O I
10.1124/dmd.107.017566
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Silymarin, a mixture of polyphenolic flavonoids extracted from milk thistle (Silybum marianum), is composed mainly of silychristin, silydianin, silybin A, silybin B (SBB), isosilybin A (ISBA), and isosilybin B. In this study, the plasma concentrations of free (unconjugated), conjugated (sulfated and glucuronidated), and total (free and conjugated) silymarin flavonolignans were measured using liquid chromatography-electrospray ionization-mass spectrometry, after a single oral dose of 600 mg of standardized milk thistle extracts to three healthy volunteers. Pharmacokinetic analysis indicated that silymarin flavonolignans were rapidly eliminated with short half-lives (1 -3 and 3 -8 h for free and conjugated, respectively). The AUC(0 ->infinity) values of the conjugated silymarin flavonolignans were 4-to 30-fold higher than those of their free fractions, with SBB (mean AUC(0 ->infinity) =51 and 597 mu g center dot h/l for free and conjugated, respectively) and ISBA (mean AUC(0 infinity ->) = 30 and 734 mu g center dot h/l for free and conjugated, respectively) exhibiting higher AUC(0 ->infinity) values in comparison with other flavonolignans. Near the plasma peak times (1 -3 h), the free, sulfated, and glucuronidated flavonolignans represented approximately 17, 28, and 55% of the total silymarin, respectively. In addition, the individual silymarin flavonolignans exhibited quite different plasma profiles for both the free and conjugated fractions. These data suggest that, after oral administration, silymarin flavonolignans are quickly metabolized to their conjugates, primarily forming glucuronides, and the conjugates are primary components present in human plasma.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 28 条
[1]   A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease [J].
Ball, KR ;
Kowdley, KV .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (06) :520-528
[2]   PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].
BARZAGHI, N ;
CREMA, F ;
GATTI, G ;
PIFFERI, G ;
PERUCCA, E .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338
[3]   Silymarin as a new hepatoprotective agent in experimental cholestasis: New possibilities for an ancient medication [J].
Crocenzi, FA ;
Roma, MG .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (09) :1055-1074
[4]   Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide [J].
D'Andrea, V ;
Pérez, LM ;
Pozzi, EJS .
LIFE SCIENCES, 2005, 77 (06) :683-692
[5]  
DESPLACES A, 1975, ARZNEIMITTEL-FORSCH, V25, P89
[6]   Polyphenols and gastrointestinal diseases [J].
Dryden, GW ;
Song, M ;
McClain, C .
CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (02) :165-170
[7]   Milk thistle (Silybum marianum) for the therapy of liver disease [J].
Flora, K ;
Hahn, M ;
Rosen, H ;
Benner, K .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (02) :139-143
[8]   Pharmacology of silymarin [J].
Fraschini, F ;
Demartini, G ;
Esposti, D .
CLINICAL DRUG INVESTIGATION, 2002, 22 (01) :51-65
[9]  
GATTI G, 1994, INT J CLIN PHARM TH, V32, P614
[10]   Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process [J].
Han, YH ;
Lou, HX ;
Ren, DM ;
Sun, LR ;
Ma, B ;
Ji, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (05) :1071-1078